Insulin therapy in type 2 diabetes is no longer a secondary care activity in the Netherlands

Primary Care Diabetes

Volumn 3, Issue 1, 2009, Pages 23-28

  van Avendonk, Mariëlle J P ^a   Gorter, Kees J ^a   van den Donk, Maureen ^a   Rutten, Guy E H M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Diabetes mellitus type 2; Insulin therapy; Primary care

Indexed keywords

ARTICLE; DRUG MONITORING; FINANCIAL MANAGEMENT; GENERAL PRACTICE; GENERAL PRACTITIONER; INSULIN TREATMENT; MEDICAL CARE; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE PRACTITIONER; PATIENT CARE; PHARMACEUTICAL CARE; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; PUBLIC HEALTH SERVICE;

ADULT; AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; DIABETES MELLITUS, TYPE 2; DRUG MONITORING; FAMILY PRACTICE; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; NETHERLANDS; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; QUESTIONNAIRES; REFERRAL AND CONSULTATION; REIMBURSEMENT, INCENTIVE; TIME FACTORS;

EID: 62949129632     PISSN: 17519918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcd.2008.10.007     Document Type: Article

References (28)

1. Rutten G.E.H.M., De Grauw W.J.C., Nijpels G., Goudswaard A.N., Uitewaal P.J.M., Van der Does F.E.E., Heine R.J., van Ballegooie E., Verduijn M.M., and Bouma M. Guideline on diabetes care of the Dutch college of GPs (NHG Standaard Diabetes Mellitus type 2). Huisarts en Wetenschap 49 (2006) 137-152
2. Goyder E.C., McNally P.G., Drucquer M., Spiers N., and Botha J.L. Shifting of care for diabetes from secondary to primary care, 1990-5: review of general practices. BMJ 316 (1998) 1505-1506
3. Khunti K., and Ganguli S. Who looks after people with diabetes: primary or secondary care?. J. R. Soc. Med. 93 (2000) 183-186
4. Brunton S., Carmichael B., Funnel M., Lorber D., Rakel R., and Rubin R. The role of insulin. Type 2 diabetes. Fam. Pract. Suppl. (2005) 445-452
5. Van Avendonk M., Gorter K., Van den Donk M., and Rutten G.E. Niet alle huisartsen hebben de praktijkorganisatie om optimale diabeteszorg te leveren. Een vragenlijstonderzoek. (Not all general practitioners have the practice organisation to provide optimal diabetes care. A questionnaire survey). Huisarts en Wetenschap 50 (2007) 529-534
6. Hunt L.M., Valenzuela M.A., and Pugh J.A. NIDDM patients' fears and hopes about insulin therapy-the basis of patient reluctance. Diabetes Care 20 (1997) 292-298
7. Snoek F. Breaking the barriers to optimal glycaemic control-what physicians need to know from patients' perspectives. Int. J. Clin. Pract. Suppl. 129 (2002) 80-84
8. Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int. J. Obesity 26 Suppl. 3 (2002) s18-s24
9. M. Peyrot, R.R. Rubin, T. Lauritzen, S.E. Skovlund, F.J. Snoek, D.R. Matthews, R. Landgraf, L. Kleinebreil, on behalf of the International DAWN Advisory Panel, Resistance to Insulin Therapy Among Patients and Providers: Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study, Diabetes Care 28 (2005) 2673-2679.
10. Mollema E.D., Snoek F.J., Pouwer F., Heine R.J., and van der Ploeg H.M. Diabetes fear of injecting and self-testing questionnaire: a psychometric evaluation. Diabetes Care 23 (2000) 765-769
11. Veltmaat L.J., Miedema K., and Reenders K. Overschakeling op insuline bij NIADM-patiënten. (Conversion to insulin in not insulin dependent diabetes mellitus patients), in Dutch with English abstract. Huisarts en Wetenschap 38 (1995) 608-613
12. Riddle M.C. The underuse of insulin therapy in North America. Diabetes Metab. Res. Rev. 18 (2002) S42-S49
13. Kenens R., and Hingstman L. Cijfers uit de registratie van huisartsen. Peiling 2004 (General Practitioners registration. Survey 2004) (2004), The Netherlands Institute for Health Services Research (NIVEL)
14. Jeavons D., Hungin A.P.S., and Cornford C.S. Patients with poorly controlled diabetes in primary care: healthcare clinicians' beliefs and attitudes. Postgrad. Med. J. 82 (2006) 347-350
15. Davis S.N., and Renda S.M. Psychological insulin resistance: overcoming barriers to starting insulin therapy. Diabetes Educ. 32 (2006) 146S-152S
16. Goudswaard A.N., Stolk R.P., Zuithoff P., de Valk H.W., and Rutten G.E. Starting insulin in type 2 diabetes: continue oral hypoglycemic agents? A randomized trial in primary care. J. Fam. Pract. 53 (2004) 393-399
17. A.N. Goudswaard, F.N.J. Furlong, G.D. Valk, R.P. Stolk, G.E. Rutten, Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus, Cochrane Collaboration, Metabolic and Endocrine Disorders Group 2004, 2004.
18. Haque M., Hayden Emerson S., Dennison C.R., Navsa M., and Levitt N.S. Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town. SAMJ 95 (2005) 798-802
19. Goudswaard A.N., Stolk R.P., Zuithoff N.P.A., de Valk H.W., and Rutten G.E.H.M. Long-term effects of self-management education for patients with Type 2 diabetes taking maximal oral hypoglycaemic therapy: a randomized trial in primary care. Diabetic Med. 21 (2004) 491-496
20. Berghout L., Gorter K.J., and Rutten G.E. Improvement of glycemic regulation without exogenous insulin in 40% of poorly regulated patients with type 2 diabetes mellitus; a study in 18 family practices. Ned Tijdschr Geneeskd 145 (2001) 2035-2039
21. Spoelstra J.A., Stol R.P., de Bruyne M.C., Erkens J.A., Herings R.M., Leufkens H.G., and Grobbee D.E. Factors associated with switching from oral hypoglycaemic agents to insulin therapy. Neth. J. Med. 60 (2002) 243-248
22. Mazzaglia G., Yurgin N., Boye K.S., Trifirò G., Cottrell S., Allen E., Filippi A., Medea G., and Cricelli C. Prevalence and antihyperglycemic prescribing trends for patients with type 2 diabetes in Italy: a 4-year retrospective study from national primary care data. Pharmacol. Res. 57 (2008) 358-363
23. Yurgin N., Secnik K., and Lage M.J. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study. Clin. Ther. 29 (2007) 316-325
24. B. Eliasson, K. Eeg-Olofsson, J. Cederholm, P. Nilsson, S. Gudbjornsdottir, Steering Committee of the Swedisch National Diabetes Register (NDR), Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register. Diabetes Metab. 33 (2007) 269-276.
25. de Sonnaville J.J., Snoek F.J., Colly L.P., Deville W., Wijkel D., and Heine R.J. Well-being and symptoms in relation to insulin therapy in type 2 diabetes. Diabetes Care 21 (1998) 919-924
26. de Grauw W.J., van de Lisdonk E.H., van Gerwen W.H., van den Hoogen H.J., and van Weel C. Insulin therapy in poorly controlled type 2 diabetic patients: does it affect quality of life?. Br. J. Gen. Pract. 51 (2001) 527-532
27. Tahrani A., McCarthy M., Godson J., Taylor S., Slater H., Capps N., et al. Diabetes care and the GMS contract: the evidence for a whole county. Br. J. Gen. Pract. 57 (2007) 483-485
28. Campbell S., Reeves D., Kontopantelis E., Middleton E., Sibbald B., and Roland M. Quality of primary care in England with the introduction of pay for performance. N. Engl. J. Med. 357 (2007) 181-190